company background image
UNIO

Union Diagnostic and Clinical ServicesNGSE:UNIONDAC Stock Report

Market Cap

₦994.9m

7D

0%

1Y

7.7%

Updated

17 Oct, 2021

Data

Company Financials
UNIONDAC fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

UNIONDAC Overview

Union Diagnostic and Clinical Services Plc provides laboratory and clinical services primarily in Nigeria.

Price History & Performance

Summary of all time highs, changes and price drops for Union Diagnostic and Clinical Services
Historical stock prices
Current Share Price₦0.28
52 Week High₦0
52 Week Low₦0
Beta-0.031
1 Month Change0%
3 Month Change0%
1 Year Change7.69%
3 Year Change0%
5 Year Change-44.00%
Change since IPO-89.82%

Recent News & Updates

Shareholder Returns

UNIONDACNG HealthcareNG Market
7D0%0.7%1.6%
1Y7.7%29.5%40.0%

Return vs Industry: UNIONDAC underperformed the NG Healthcare industry which returned 28.9% over the past year.

Return vs Market: UNIONDAC underperformed the NG Market which returned 40% over the past year.

Price Volatility

Is UNIONDAC's price volatile compared to industry and market?
UNIONDAC volatility
UNIONDAC Beta-0.031
Industry Beta0.39
Market Beta1

Stable Share Price: UNIONDAC is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 0% a week.

Volatility Over Time: UNIONDAC's weekly volatility has decreased from 5% to 0% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994486A. Akinniyihttps://www.uniondiagnostic.com.ng

Union Diagnostic and Clinical Services Plc provides laboratory and clinical services primarily in Nigeria. The company offers pathology services in the areas of chemical pathology, immunoassay, haematology and blood transfusion, microbiology, parasitology, virology, molecular lab and DNA testing, mycology, and cytology and histology; ultrasound, X-ray imaging, mammography, CT scan, and MRI services; and ECG, EEG, audiometry, and spirometry services. It also provides gastroscopy, colonoscopy, sigmoidoscopy proctoscopy, laparoscopy and dye test, bronchoscopy, and cystoscopy services, as well as renal dialysis services.

Union Diagnostic and Clinical Services Fundamentals Summary

How do Union Diagnostic and Clinical Services's earnings and revenue compare to its market cap?
UNIONDAC fundamental statistics
Market Cap₦994.88m
Earnings (TTM)₦20.67m
Revenue (TTM)₦1.42b

48.2x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
UNIONDAC income statement (TTM)
Revenue₦1.42b
Cost of Revenue₦425.64m
Gross Profit₦996.98m
Expenses₦976.31m
Earnings₦20.67m

Last Reported Earnings

Dec 31, 2020

Next Earnings Date

n/a

Earnings per share (EPS)0.0058
Gross Margin70.08%
Net Profit Margin1.45%
Debt/Equity Ratio58.1%

How did UNIONDAC perform over the long term?

See historical performance and comparison

Valuation

Is Union Diagnostic and Clinical Services undervalued compared to its fair value and its price relative to the market?

48.19x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate UNIONDAC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate UNIONDAC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: UNIONDAC is poor value based on its PE Ratio (48.2x) compared to the African Healthcare industry average (32.3x).

PE vs Market: UNIONDAC is poor value based on its PE Ratio (48.2x) compared to the NG market (7.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate UNIONDAC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: UNIONDAC is good value based on its PB Ratio (0.2x) compared to the XF Healthcare industry average (2.7x).


Future Growth

How is Union Diagnostic and Clinical Services forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Union Diagnostic and Clinical Services has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Union Diagnostic and Clinical Services performed over the past 5 years?

-44.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: UNIONDAC has a high level of non-cash earnings.

Growing Profit Margin: UNIONDAC's current net profit margins (1.5%) are lower than last year (4.6%).


Past Earnings Growth Analysis

Earnings Trend: UNIONDAC's earnings have declined by 44.3% per year over the past 5 years.

Accelerating Growth: UNIONDAC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: UNIONDAC had negative earnings growth (-66.6%) over the past year, making it difficult to compare to the Healthcare industry average (4.5%).


Return on Equity

High ROE: UNIONDAC's Return on Equity (0.5%) is considered low.


Financial Health

How is Union Diagnostic and Clinical Services's financial position?


Financial Position Analysis

Short Term Liabilities: UNIONDAC's short term assets (NGN2.4B) exceed its short term liabilities (NGN159.9M).

Long Term Liabilities: UNIONDAC's short term assets (NGN2.4B) do not cover its long term liabilities (NGN2.6B).


Debt to Equity History and Analysis

Debt Level: UNIONDAC's debt to equity ratio (58.1%) is considered high.

Reducing Debt: UNIONDAC's debt to equity ratio has increased from 1.2% to 58.1% over the past 5 years.

Debt Coverage: UNIONDAC's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: UNIONDAC earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Union Diagnostic and Clinical Services's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate UNIONDAC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate UNIONDAC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if UNIONDAC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if UNIONDAC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of UNIONDAC's dividend in 3 years as they are not forecast to pay a notable one for the NG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

A. Akinniyi

no data

Tenure

Dr. A. Olusola Akinniyi, MB, BS, MBA, FWACS serves as the Managing Director, Chief Executive Officer and a Director at Union Diagnostic and Clinical Services Plc. Mr. Akinniyi is a Consultant Gynaecologist...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Union Diagnostic and Clinical Services Plc's employee growth, exchange listings and data sources


Key Information

  • Name: Union Diagnostic and Clinical Services Plc
  • Ticker: UNIONDAC
  • Exchange: NGSE
  • Founded: 1994
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: ₦994.879m
  • Shares outstanding: 3.55b
  • Website: https://www.uniondiagnostic.com.ng

Number of Employees


Location

  • Union Diagnostic and Clinical Services Plc
  • 5, Eletu Ogabi Street
  • Off Adeola Odeku Street
  • Lagos
  • Nigeria

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/17 15:22
End of Day Share Price2021/10/15 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.